RecruitingNot applicableNCT07177482

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

Studying Craniopharyngioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Deling Li
Principal Investigator
Deling Li, MD
Beijing Tiantan Hospital
Intervention
68Ga-MY6349 PET/CT(diagnostic_test)
Enrollment
20 enrolled
Eligibility
14-80 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Collaborators

Peking Union Medical College Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07177482 on ClinicalTrials.gov

Other trials for Craniopharyngioma

Additional recruiting or active studies for the same condition.

See all trials for Craniopharyngioma →

← Back to all trials